Jon Zugazagoitia

6PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 12, 2026
Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer.

|Aug 29, 2024
CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.

Anaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui

|Apr 17, 2024
Facts and Hopes on Cancer Immunotherapy for Small Cell Lung Cancer.

Jon Zugazagoitia, Handerson Osma, Javier Baena

|Apr 17, 2024
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.

Melina Peressini, Rosario Garcia-Campelo, Bartomeu Massuti

|Jun 13, 2023
PTEN Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells.

Francisco Exposito, Miriam Redrado, Maeva Houry

|Aug 24, 2022
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer.

Myrto K Moutafi, Magdalena Molero, Sandra Martinez Morilla

Pageof 1

Frequent Collaborators

4 joint publications

Luis Paz-Ares

3 joint publications

Magdalena Molero-Abraham

2 joint publications

Javier Baena

2 joint publications

Angel Nuñez-Buiza